Your browser doesn't support javascript.
loading
Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T-cells-mediated IL-9 gene expression in toluene-2,4-diisocyanate-sensitized rats.
Mizuguchi, Hiroyuki; Orimoto, Naoki; Kadota, Takuya; Kominami, Takahiro; Das, Asish K; Sawada, Akiho; Tamada, Misaki; Miyagi, Kohei; Adachi, Tsubasa; Matsumoto, Mayumi; Kosaka, Tomoya; Kitamura, Yoshiaki; Takeda, Noriaki; Fukui, Hiroyuki.
Afiliação
  • Mizuguchi H; Department of Molecular Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Sho-machi, Tokushima 770-8505, Japan. Electronic address: guchi003@tokushima-u.ac.jp.
  • Orimoto N; Department of Molecular Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Sho-machi, Tokushima 770-8505, Japan; Taiho Pharmaceutical Co. LTD., 224-2, Ebisuno Hiraishi, Kawauchi-cho, Tokushima 771-0194, Japan.
  • Kadota T; Department of Molecular Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Sho-machi, Tokushima 770-8505, Japan.
  • Kominami T; Department of Molecular Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Sho-machi, Tokushima 770-8505, Japan.
  • Das AK; Department of Molecular Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Sho-machi, Tokushima 770-8505, Japan.
  • Sawada A; Department of Molecular Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Sho-machi, Tokushima 770-8505, Japan.
  • Tamada M; Department of Molecular Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Sho-machi, Tokushima 770-8505, Japan.
  • Miyagi K; Department of Molecular Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Sho-machi, Tokushima 770-8505, Japan.
  • Adachi T; Department of Molecular Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Sho-machi, Tokushima 770-8505, Japan.
  • Matsumoto M; Department of Molecular Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Sho-machi, Tokushima 770-8505, Japan.
  • Kosaka T; Department of Molecular Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Sho-machi, Tokushima 770-8505, Japan.
  • Kitamura Y; Department of Otolaryngology, Institute of Biomedical Sciences, Tokushima University Graduate School, Kuramoto, Tokushima 770-8503, Japan.
  • Takeda N; Department of Otolaryngology, Institute of Biomedical Sciences, Tokushima University Graduate School, Kuramoto, Tokushima 770-8503, Japan.
  • Fukui H; Department of Molecular Studies for Incurable Diseases, Institute of Biomedical Sciences, Tokushima University Graduate School, Kuramoto, Tokushima 770-8503, Japan.
J Pharmacol Sci ; 130(3): 151-8, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26874672

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Sulfônio / Doenças Nasais / Interleucina-9 / Sulfonatos de Arila / Tolueno 2,4-Di-Isocianato / Antialérgicos / Fatores de Transcrição NFATC / Antagonistas dos Receptores Histamínicos / Hipersensibilidade Tipo de estudo: Diagnostic_studies Limite: Animals Idioma: En Revista: J Pharmacol Sci Assunto da revista: FARMACOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de publicação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Sulfônio / Doenças Nasais / Interleucina-9 / Sulfonatos de Arila / Tolueno 2,4-Di-Isocianato / Antialérgicos / Fatores de Transcrição NFATC / Antagonistas dos Receptores Histamínicos / Hipersensibilidade Tipo de estudo: Diagnostic_studies Limite: Animals Idioma: En Revista: J Pharmacol Sci Assunto da revista: FARMACOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de publicação: Japão